Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Prostate Cancer / July 2005

Tip: Looking for answers? Try searching our database.

Results of RP vs RT at 5 and 9 years out

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
Steve U - 05 Jul 2005 14:39 GMT
Saw this in the July 2005 Journal of Urology:
INTERMEDIATE TERM BIOCHEMICAL PROGRESSION RATES AFTER RADICAL
PROSTATECTOMY AND RADIOTHERAPY IN PATIENTS WITH SCREEN DETECTED
PROSTATE CANCER.
Journal of Urology. 174(1):126-130, July 2005.
KRYGIEL, JULIE M. *+++; SMITH, DEBORAH S. ++; HOMAN, SHARON M. ++;
SUMNER, WALTON II ++; NEASE, ROBERT F. JR ++; BROWNSON, ROSS C. ++;
CATALONA, WILLIAM J. [S]
Abstract:
Purpose: We compared biochemical progression rates measured by
increasing prostate specific antigen (PSA) levels using a standard
definition of biochemical recurrence among patients with screen
detected prostate cancer treated with radical prostatectomy (RP) or
radiotherapy (RT).

Materials and Methods: A total of 1,939 patients diagnosed with
clinically localized prostate cancer in a community based screening
study from 1989 to 1998, followed through 2001, were treated with RP or
RT and agreed to enroll in a followup study. This prospective cohort
study (median followup 62 months, range 0.2 to 141) used adjusted Cox
proportional hazards models to examine time to progression. Selection
bias was addressed with propensity scores. Biochemical evidence of
cancer progression was defined as PSA greater than 0.2 ng/ml in
patients who underwent RP and 3 consecutive PSA increases as
recommended by the American Society for Therapeutic Radiology and
Oncology criteria for radiotherapy.

Results: Of the patients 17% had evidence of cancer progression. The
percentage with progression-free survival at 5 and 9 years for RP was
84% and 76%, respectively, and for RT 80% and 70%, respectively. Cox
proportional hazards models produced a hazard ratio of 1.63 (95% CI,
1.12, 2.38) for RT compared with RP, adjusting for clinical stage,
Gleason grade, preoperative PSA, biopsy age, treatment year and
propensity for treatment type.

Conclusions: With intermediate term followup, patients treated with RT
were more likely to have cancer progression than with RP adjusting for
demographics, clinical factors, selection bias and treatment year.

Copyright (C) 2005 by American Urological Association, Inc.

Steve U
ron - 05 Jul 2005 15:02 GMT
Steve U wrote...snip...
Biochemical evidence of cancer progression was defined as PSA greater
than 0.2 ng/ml in patients who underwent RP and 3 consecutive PSA
increases as recommended by the American Society for Therapeutic
Radiology and Oncology criteria for radiotherapy.

-------------------------------------------------------------------------

Conclusions based on studies using different definitions of failure to
compare arms of the study are meaningless at best and misleading at
worst.  Is 32C the same as 32F, then why should failure rates based on
PSA>.2 mean anything in comparison to failure rates based on ASTRO?  It
has been shown in a large number of studies that ASTRO is 8-40%
(depending upon length of time of study and cohort makeup) more
forgiving in defining biochemical recurrence than PSA>0.2...Ron
Steve U - 05 Jul 2005 20:55 GMT
Ron,
If ASTRO is more"forgiving", then doesn't that just further support the
articles conclusions?
Steve U
ron - 05 Jul 2005 22:30 GMT
> Ron,
> If ASTRO is more"forgiving", then doesn't that just further support the
> articles conclusions?
> Steve U

Steve...Yes, it does.  Nonetheless, I worry about studies that use
erroneous methodologies (in this case making comparisons using two
different definitions of failure) to draw their conclusions.

In addition to this issue, the abstract states, "patients treated with
RT
were more likely to have cancer progression than with RP."  This
statement surprised me too.  What do the authors mean by "RT"; seeds,
EBRT, or seeds + EBRT?  Other published data suggests that RRP
(Hopkins) and SI+EBRT (RCOG) have comparable freedom from biochemical
recurrence.  Using "RT" just seems like a sloppy way to present things
in the abstract.  Dr. Catalona is a noted researcher, I suspect this
point (and perhaps use of the different DOFs, as well) is discussed in
the full paper.

My original post reflected my concern with the author's methodology
based on the abstract.  Their conclusions (depending upon what they
mean by "RT") may, in fact, be correct...Best wishes and good health,
Ron
Leonard Evens - 06 Jul 2005 01:53 GMT
>>Ron,
>>If ASTRO is more"forgiving", then doesn't that just further support the
[quoted text clipped - 15 lines]
> point (and perhaps use of the different DOFs, as well) is discussed in
> the full paper.

Actually, it isn't adequately discussed.  There is a brief discussion in
which it is noted that it might have been interesting to stratify the
study by comparing external radiation to seeds, but that only a few men
were treated by seeds (51) because it was just starting at their
institution.   They also note that they had no information on whether
hormone therapy was used as a supplement for any of the RT cases.

All told, it seems to me that the questions you raise were not answered
in the original paper.  At best this can be taken as a rough comparison
of treatment methods as they were actually used in a community setting.
 Sometimes, authorities argue that it is appropriate to proceed that
way beause it is actually what gets done in real life that counts, not
what theoretically could have been done under ideal circumstances.
Myself, I don't buy that argument.  To compare two treatment methods
scientifically, you would want to choose the best practitioners of each
and compare them head to head.

> My original post reflected my concern with the author's methodology
> based on the abstract.  Their conclusions (depending upon what they
> mean by "RT") may, in fact, be correct...Best wishes and good health,
> Ron
ron - 06 Jul 2005 02:52 GMT
Leonard wrote...snip...
At best this can be taken as a rough comparison of treatment methods

But Leonard, how can it even be considered a "rough" comparison.  If
we're talking and I tell you the temperature at my place is 32C
(southern India, I guess), and then you add that the temperature at
your place is 32F, would I be correct to say, "Oh, we're experiencing
the same temperature, we're both at 32 degrees"?  That assertion is no
more correct than saying that since the biochemical failure rate on the
RT population is X% using ASTRO, and since the biochemical failure rate
on the RP population is  X% using PSA>.2, the two modalities have the
same biochemical failure rate...Ron
Leonard Evens - 06 Jul 2005 15:30 GMT
> Leonard wrote...snip...
> At best this can be taken as a rough comparison of treatment methods
[quoted text clipped - 8 lines]
> on the RP population is  X% using PSA>.2, the two modalities have the
> same biochemical failure rate...Ron

I guess one answer is that if you are an "average" man going to an
"average" therpaist using "average" procedures and "average" criteria
for recursion, then in the end you are on the average a bit better off
after RP than after RT.  Unfortunately, that doesn't tell you much about
how any particular man with a particular therapist will do.

Presumably the criteria for recurrence in either case are related to
clinical symptoms of recurrence at a later date and something is known
about that from other studies.  It seems reasonable that the criteria
for PSA recurrence in each case were derived with such studies in mind,
and the ultimate consequences are at least roughly the same.

But your point is well taken, and some prostate cancer experts have
raised it.
Alan Meyer - 06 Jul 2005 16:02 GMT
> ...
> I guess one answer is that if you are an "average" man going to an "average" therpaist
> using "average" procedures and "average" criteria for recursion, then in the end you are
> on the average a bit better off after RP than after RT.  Unfortunately, that doesn't
> tell you much about how any particular man with a particular therapist will do.
> ...

Your point about the skill of the practitioner seems very cogent to
me.  Patrick Walsh reports higher success rates than just about
anyone else, and it may have to do with his being one of the highest
skilled surgeons in the world for RRP.

After going through radiation, I'm convinced that skill is also highly
important for RT also.  Getting the exact position right, the right dose,
placing the seeds correctly for brachytherapy, etc. are all high
skill, high knowledge, high precision operations.

I notice that one of the authors of the study is William Catalona,
a renowned surgeon.  I wonder if a high percentage of the surgery
patients were treated by him.

   Alan
Clarence Crow - 06 Jul 2005 00:05 GMT
<snip>
>Conclusions: With intermediate term followup, patients treated with RT
>were more likely to have cancer progression than with RP adjusting for
>demographics, clinical factors, selection bias and treatment year.
>
>Copyright (C) 2005 by American Urological Association, Inc.

You know what's wrong with you Yanks who tend to research and post all
this stuff? You tend to believe it as final and true. Tomorrow,
someone else will authoritively post something totally 180 Degrees
juxtapositioned, and then where will you be?
You all read books on PCa and do you wake up in the morning cured? NO!
You all talk Doctors' jargon, but for why?

IMHO, just get on with your lot whatever it is, and survive in hope
for a longer life with some degree of quality.


 
-- Reader to complete...
-- Please reply to this ng as my email adress is fake:

-- Regards

-- CC
ron - 06 Jul 2005 01:27 GMT
Clarence...Why does something have to be "wrong with you" to discuss
medical information that is relevant to a condition you have?  And in
some of the other PCa groups I look in on, it is not just the Yanks who
do such posting.  There from every continent.  I understand and accept
that it is not everyone's cup of tea, but for those who choose to
participate, it's an acceptable method to
try and discover the truth
accept and come to grips with your illness
help and support others in their process
prepare yourself for a range of possible future eventuallities
decompress, have fun by working on puzzles
etc., etc.

I don't think that there is much about PCa that has changed 180 degrees
in the few years I've been on board.  Just cut others a bit more slack.
If people get some satisfaction posting / discussing this kind of
stuff, then they probably derive some benefit from it, and that's great
for them...Ron
Clarence Crow - 07 Jul 2005 03:10 GMT
<snip>

>I don't think that there is much about PCa that has changed 180 degrees
>in the few years I've been on board.  Just cut others a bit more slack.
> If people get some satisfaction posting / discussing this kind of
>stuff, then they probably derive some benefit from it, and that's great
>for them...Ron
Ron

This week I'm a little stressed out.

-- Reader to complete...
-- Please reply to this ng as my email adress is fake:

-- Regards

-- CC
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.